| Jessie Lawson, | |
|
14440 Cherry Lane Ct Ste 208, Laurel, MD 20707-4946 | |
| (301) 604-1458 | |
| Not Available |
| Full Name | Jessie Lawson |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 14440 Cherry Lane Ct Ste 208, Laurel, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033804521 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 23267 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessie Lawson, 14440 Cherry Lane Ct Ste 208, Laurel, MD 20707-4946 Ph: () - | Jessie Lawson, 14440 Cherry Lane Ct Ste 208, Laurel, MD 20707-4946 Ph: (301) 604-1458 |
News Archive
Bristol-Myers Squibb Company today announced results from a Phase II clinical trial in which treatment with the investigational direct-acting antiviral BMS-790052, an NS5A replication complex inhibitor, in combination with PEG-Interferon alfa and ribavirin, achieved sustained virologic response 12 weeks post-treatment in up to 92% of treatment-naïve patients chronically infected with hepatitis C genotype 1.
Researchers at National Jewish Medical and Research Center report in the March issue of Cancer Research that a pair of promising proteins, known as fibulins 3 and 5, slow the growth of cancer tumors in mice by preventing blood vessels from sprouting. The proteins are promising candidates for use in cancer therapy.
Schering-Plough Corporation has announced that the European launch of Bridion (sugammadex) injection has begun with its introduction this week in Sweden, and that the product is expected to be available soon in the United Kingdom and Germany, with several other European markets to follow by the end of the year and in early 2009.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
Bacteria are pretty wily creatures. Take for example, an organism such as Salmonella, which which are killed by antibiotics in lab tests, but can become highly resistant in the body.
› Verified 7 days ago
Dedrie Boykin, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9208 Redbridge Ct, Laurel, MD 20723 Phone: 240-350-9281 | |
Vanesta Louise Poitier, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9285 Livery Ln, Apt C, Laurel, MD 20723 Phone: 240-280-4890 | |
Wanda L Finch, LICSW, CAS Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 13003 N Point Ln, Laurel, MD 20708 Phone: 301-776-6574 | |
Jenny Winkert, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 14440 Cherry Lane Ct Ste 208, Laurel, MD 20707 Phone: 301-604-1458 | |
Kirsten Dawkins, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9811 Mallard Dr Ste 203, Laurel, MD 20708 Phone: 301-778-8835 | |
Dr. Donald Ray Soeken, LCSW-C, PH.D. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15702 Tasa Place, Laurel, MD 20707 Phone: 301-953-7353 |